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ABSTRACT
Objective: The aim of the present work is to use experimental design to screen and optimize experimental variables for developing a colorimetric first-
order derivative method for determining content of serralysin (SER) using biuret and Folin–Ciocalteu phenol reagent for stable color development. The 
method is based on the reaction of peptide bond in the protein with Biuret reagent in alkaline medium and further reaction of remaining tryptophan 
and tyrosine residues with Folin–Ciocalteu Phenol reagent to form a stable blue-colored complex (first-order derivative λmax 620 nm).
Materials and Methods: A two-level full factorial design was utilized to screen the effect of Volume of NaOH (A), volume of biuret reagent (B), volume 
of Folin–Ciocalteu phenol reagent (C), and concentration of NaOH (D) on the formation of blue-colored SER - reagent complex (response - absorbance). 
A box Behnken experimental design with response surface methodology was then utilized to evaluate the main interaction and quadratic effects of 
these factors on the selected response.
Results: With the help of a response surface plot and contour plot, the optimum values of the selected factors were determined and used for further 
experiments. These values were volume of NaOH (A) of 1.0 mL, volume of biuret reagent (B) of 0.25 mL, and volume of Folin–Ciocalteu phenol reagent 
(C) of 10 µL. The proposed method was validated according to the ICH Q2(R1) method validation guidelines. The developed colorimetric first-order 
derivative method was found to be simple, accurate, rapid, sensitive, precise, and economic. Further optimization of the method with experimental 
design approach makes it convenient for use in laboratory.
Conclusion: The results of present study have clearly shown that an experimental design approach may be effectively applied to the optimization of a 
modified visible spectrophotometric method for estimation of SER in bulk and in pharmaceutical formulation with the least number of experimental 
runs possible. The method can be employed successfully for the estimation of SER in both bulk and tablet dosage form.
Keywords: Serralysin, Experimental design, Box–Behnken Model, Colorimetric, First-order derivative, Biuret, Folin–Ciocalteu.
INTRODUCTION
Analytical studies, related to the quality control and routine analysis 
of commercial products in the research or industry laboratories, use 
spectrophotometric methods such as derivative spectrophotometry. 
These spectrophotometric methods are found to be preferable instead 
of hyphenated analytical instrumentations or techniques such as liquid 
chromatography-mass spectrometry (LC-MS), gas chromatography-MS, 
LC-nuclear magnetic resonance, etc., which always require prior steps 
such as extraction and other tedious analytical process during analysis [1].
Serralysin (SER) (CAS registry number: 70851-98-8, EC 3.4.24.40) 
has a long history in medicine and is widely used to combat various 
kinds of inflammation and inflammatory disorders. SER is a proteolytic 
enzyme isolated from the non-pathogenic enterobacteria Serratia E 
15 found in silkworms [2]. A recent finding suggests that the enzyme 
reduces capillary permeability induced by histamine, bradykinin, and 
serotonin; it dissolves the abnormal exudates and proteins by breaking 
it down and facilitates the absorption of decomposed products through 
blood and lymphatics [3]. Thus, SER acts as a potent anti-inflammatory 
agent. The enzyme has a molecular weight of 45–60 KD and is a 
metalloprotease containing a zinc atom which is important for its 
proteolytic activity (Fig. 1).
Implementation of quality by design for analytical methods during 
development allows for enhanced understanding of the analytical 
method focusing on robustness and ruggedness, thereby facilitating 
method transfer and providing opportunities for continual 
improvement [4]. Two-level full factorial design is used for screening 
the important factors that influence the response. Factorial designs are 
advantageous over one factor at a time (OFAT) method as it gives wider 
inductive basis to draw inferences about the process and it also reveals 
“interactions” of factors. A two-level full factorial design consists of 2 
levels of each experimental factor. It provides direction for further 
experimentation [5].
Response surface methodology (RSM) is a statistical technique used for 
the development and optimization of complex processes [6-8]. Different 
types of response surface designs are used for optimization such as 
central composite design (CCD) and Box–Behnken design (BBD). The 
beauty of BBD is that it requires fewer test runs and is rotatable [9].
The BBD is advantageous because it does not contain any points at 
the extremes of the cubic region created by the two-level factorial 
combinations [6,7,10]. BBD is a second-order quadratic model for 
non-linear responses which is mainly used when the factor space is 
within the experimental domain [11]. The BBD was selected in the 
present investigation and used to optimize and validate a modified 
spectrophotometric method for estimating SER because the design 
provides three levels for each factor and requires fewer runs as 
compared to CCD.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i9.26999
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Numerous studies have been carried out for quantitative and qualitative 
estimation of SER [12]. Thin-layer chromatography [13], SDS-PAGE 
gel electrophoresis [14], and X-ray powder diffractometry [15] are 
some of the techniques reported for successful qualitative estimation 
of SER. Quantitative instrumental methods use chromatography, field 
flow fractionation, electrophoresis, etc., for separation, and physical 
properties such as absorption, fluorescence, conductivity, and light 
scattering are used to measure the analyte accurately and precisely [12]. 
For quantitative analysis, caseinolytic assay method [16-27], 
spectroscopy [28-35], fluorescence spectrometry [36], enzyme-linked 
immunosorbent assay (ELISA) [37-39], radioimmunoassay [40], 
ultraviolet (UV) microplate method [41], high-performance LC 
(HPLC) [42], and LC-MS method [43] are reported.
In the reported spectrophotometric methods, the absorbance of SER 
was measured in the UV region wavelengths. The present study uses 
a colorimetric first-order derivative analysis of SER in bulk and tablet 
formulation. For protein quantitation, the biuret method [44-47] 
and the Lowry method [48,49] have been widely used as standard 
procedures. The biuret method has a more linear correlation 
between protein concentration and absorbance but lacks sensitivity. 
Therefore, the sensitive Lowry method is more preferred. However, 
the necessity of preparing chemicals for each protein measurement 
due to poor stability of the combined reagents, instability of color 
development, the standard curve being non-reproducible, especially 
at low concentrations and non-linearity between absorbance and 
protein concentration are some of the problems associated with the 
Lowry method. In 1976, S. Ohnishi and Barry proposed a simplified 
method of quantifying protein using the biuret and phenol reagents 
where the protein sample was first treated with biuret reagent and 
then with 2 N Phenol reagent for color development. The method was 
superior to any of the widely used colorimetric method for protein 
estimation [50].
In the present work, combined application of the biuret method and the 
Lowry method in enhanced alkaline conditions is employed. The aim 
of the present work was to utilize the experimental design approach 
for screening and optimizing the experimental variables for developing 
modified colorimetric first-order derivative method for estimation of 
SER in bulk and pharmaceutical formulation.
EXPERIMENTAL
Instrument
A Jasco UV visible spectrophotometer V-730 (Spectra Manager 
Software) with 1 cm matched quartz cells was used for measuring 
absorbance.
MATERIALS AND METHODS
SER was purchased from Analab Fine chemicals, Mumbai (Maharashtra). 
Cipzen forte tablets (10 mg) and Bidanzen (5 mg) were purchased from 
the local medical shop. Analytical grade chemicals (biuret reagent, 
sodium hydroxide, Folin–Ciocalteu’s phenol reagent) and distilled 
water were used in the experiments.
Reagents and standards
Stock biuret reagent from Analab Fine chemicals and Folin–Cioclteu’s 
phenol reagent from MERCK were used for the work. Different 
concentrations of sodium hydroxide (0.5 N, 1.0 N, and 1.5 N) were 
prepared according to Indian Pharmacopoeia.
Standard solution for spectrophotometric method
A stock solution of SER (2000 µg/mL) was prepared by dissolving 0.2 g 
in 100 mL of distilled water.
Sample solution for spectrophotometric method
Twenty tablets of each brand were weighed and powdered. A quantity 
of powder equivalent to 10 mg of SER was transferred to 10 mL distilled 
water. The solution was sonicated in an ultrasonic bath for 10 min, 
mixed and filtered using Whatman filter paper.
MATERIALS AND METHODS
Two-level factorial design
A two-level full factorial design was employed to evaluate the effects 
of four independent factors, namely, volume of NaOH (A), volume 
of biuret reagent (B), volume of Folin–Ciocalteu phenol reagent (C), 
and concentration of NaOH (D) on absorbance R. On the basis of 
preliminary experiments, the ranges of values used in the design are the 
following: Volume of NaOH (A): 0.5–1.5 mL, volume of biuret reagent 
(B): 0.1-0.5 mL, volume of Folin–Ciocalteu phenol reagent (C): 0–10 µL 
and concentration of NaOH (D): 0.5–1.5 N. The different levels of the 
selected factors are presented in Table 1 and the design matrix of the 
two-level full factorial design is provided in Table 2. All the experimental 
runs were performed in triplicate and results are presented in Table 2.
Optimization by RSM
A three-level BBD with three center points (Table 3) was used to 
evaluate the main, interaction, and quadratic effects of volume of 
NaOH (A), volume of biuret reagent (B), and volume of Folin–Ciocalteu 
phenol reagent (C) on absorbance R. On the basis of results obtained 
by applying two-level full factorial design, it may be concluded that 
addition of Folin–Ciocalteu’s phenol reagent (C), significantly affects 
the response absorbance. However, the reproducibility was lost if 
volume of Folin–Ciocalteu’s phenol reagent is increased beyond 12 µL. 
Based on this fact, the volume of Folin–Ciocalteau’s phenol reagent was 
optimized within the range 8–12 µL. The experimental conditions that 
were maintained constant include concentration of NaOH (0.5 N) and 
the diluting solvent (distilled water). All the experimental runs were 
performed in triplicate and the results are presented in Table 3.
Linearity study
An aliquot of the standard stock solution (3.0–6.0 ml) was transferred 
to 10 ml volumetric flask. The total volume of each flask was brought 
to 10 ml with distilled water. 1.0 ml of 0.5N NaOH was added to each 
flask. The solutions were kept aside for 5 min. 0.25 ml of biuret reagent 
was then added in each flask and solution was thoroughly mixed on 
vortex for 5 min reaction time. Then, 10 µL of Folin–Ciocalteu’s phenol 
reagent was added and reaction mixture was again mixed for 1 min. The 
blue-colored reaction solution was scanned in the range of 400–800 nm 
against reagent blank. The spectra were converted in first-order 
derivative form and absorbances were measured at λmax 620 nm. (Fig. 2)
Assay of SER in pharmaceutical formulation
Aliquots of about 3 and 10 ml of the standard stock and sample 
solutions were transferred to 10 ml volumetric flask. The total volume 
of standard was brought to 10 ml with distilled water. 1 ml of 0.5 N 
Fig. 1 Serralysin structure
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NaOH was added to each flask. The solutions were kept aside for 5 min. 
0.25 ml of biuret reagent was then added in each flask and solutions 
were mixed on vortex mixer for 5 min reaction time. Then, 10 µL of 
Folin–Ciocalteu’s phenol reagent was added and reaction mixture was 
again mixed for 1 min. The spectra for standard and sample solutions 
were converted into first-order derivative spectra and absorbances 
were measured at 620 nm. The content of SER in the pharmaceutical 

















where XEst= content of SER per tablet of average weight; ASample= 
absorbance of sample solution; AStd= absorbance of standard solution; 
WStd = weight of standard (mg); WSample = weight of sample (mg); and 
XLABEL CLAIM = labeled content of SER per tablet (mg).
RESULTS AND DISCUSSION
A colorimetric derivative spectrophotometric method was 
developed and optimized for determining the content of SER 
using the biuret reagent and Folin–Ciocalteu’s phenol reagent for 
stable and reproducible color development. The use of both the 
reagents together improves the absorbance. The conversion in 
first-order derivative spectra is needed for better linearity. The 
experimental design approach was utilized for screening and 
optimizing the experimental variables of the first-order derivative 
spectrophotometric method.
Table 1: Experimental factors and response variable for two-level full factorial design
Factor Name Units Type Minimum Maximum
A Volume of NaOH ml Numeric 0.5 1.5
B Volume of biuret reagent ml Numeric 0.1 0.5
C Volume of Folin–Ciocalteu’s phenol reagent µL Numeric 0 10
D concentration of NaOH N Numeric 0.5 1.5
Response R Absorbance Abs units Goal maximum
Table 2: Experiment 24 and response value
Standard Run Factor 1 Factor 2 Factor 3 Factor 4 Response 1
A: Volume of NaOH B: Volume of biuret reagent C: Volume of FC reagent D: Concentration of NaOH Absorbance
mL mL µL N A
7 1 0.5 0.5 12 0.1 0.00050993
6 2 1.5 0.1 12 0.1 0.000391224
3 3 0.5 0.5 8 0.1 0.000693873
10 4 1.5 0.1 8 2 0.000441652
11 5 0.5 0.5 8 2 0.000816232
5 6 0.5 0.1 12 0.1 0.000350717
8 7 1.5 0.5 12 0.1 0.000620997
15 8 0.5 0.5 12 2 0.000756431
2 9 1.5 0.1 8 0.1 0.000488967
4 10 1.5 0.5 8 0.1 0.000685252
16 11 1.5 0.5 12 2 0.00046393
14 12 1.5 0.1 12 2 0.000471261
9 13 0.5 0.1 8 2 0.000561577
12 14 1.5 0.5 8 2 0.00048388
1 15 0.5 0.1 8 0.1 0.000545019
13 16 0.5 0.1 12 2 0.000456169
Table 3: Optimization method parameters for Box–Behnken experimental design
Run A: Volume of NaOH B: Volume of biuret 
reagent
C: Volume of Folin–Ciocalteu’s 
phenol reagent
Predicted response Observed response R
1 0.5 0.25 12 0.087 0.080
2 1 0.4 8 0.077 0.072
3 1 0.25 10 0.096 0.095
4 0.5 0.4 10 0.068 0.071
5 0.5 0.25 8 0.077 0.079
6 1 0.25 10 0.096 0.092
7 1 0.1 8 0.052 0.048
8 1 0.1 12 0.063 0.068
9 1 0.4 12 0.078 0.082
10 1 0.25 10 0.096 0.098
11 1 0.25 10 0.096 0.097
12 1.5 0.25 12 0.083 0.081
13 1.5 0.4 10 0.075 0.073
14 1.5 0.1 10 0.048 0.045
15 0.5 0.1 10 0.054 0.056
16 1 0.25 10 0.096 0.096
17 1.5 0.25 8 0.082 0.090
296
Asian J Pharm Clin Res, Vol 11, Issue 9, 2018, 293-300
 Manasi et al. 
Two-level full factorial design
Factorial design is a tool that allows us to experiment on many factors 
simultaneously. In proposed work, a two-level full factorial design was 
utilized to evaluate the main effect of four independent factors on the 
selected response R. The primary purpose was to identify significant 
main effects with the minimum number of experimental runs as possible.
The effects of all factors included in the experimental design on selected 
response R are shown in Table 2. An effect was considered to be 
significant at p≤0.05. The significant factor is the influencing factor. The 
effect of each factor was interpreted as the average change in response 
R as the factor changed from low to high level (Table 1). Pareto ranking 
analysis revealed that the factors that were statistically significant 
(p≤0.05) for selected response R were the volume of NaOH (A), volume 
of biuret reagent (B) and volume of Folin–Ciocalteau’s phenol reagent 
(C). The Pareto charts (Fig. 3) gives vital few effects on left and trivial 
many at right. The length of each bar in Pareto chart is equivalent to 
the magnitude of the regression coefficients of the factor. The volume of 
NaOH (A), volume of biuret reagent (B), and volume of Folin–Ciocalteu’s 
phenol reagent (C) have direct relationships with the absorbance R and 
their effects are statistically significant (p≤0.05). The Concentration of 
NaOH (D) also has a direct effect on the selected response R, but this is 
not statistically significant (p>0.05).
Box–Behnken experimental design
Using multivariate regression analysis, a fitted full quadratic model was 
obtained for the average response R, given by following equation:
R = β0+β1A+β2B+β3C+β11A2+β22B2+β33C2+β12AB+β13AC+β23BC
where R= Selected response; β0 = arithmetic mean response; and β1, β2, 
and β3= regression coefficients of the factors A, B, and C, respectively.
Tables 4 and 5 have shown the values of regression coefficients and 
their associated p-values. It may be observed that volume of NaOH (A), 
volume of biuret reagent (B), and volume of Folin–Ciocalteau’s phenol 
reagent (C) significantly affected the absorbance (R) of colored complex 
(p<0.05). An interaction was observed between the volume of NaOH (A) 
and volume of biuret reagent (B) (p=0.3351), between volume of NaOH 
(A) and volume of Folin–Ciocalteu’s phenol reagent (C) (p=8039) and it 
was also observed between volume of Biuret reagent (B) and volume of 
Folin–Ciocalteu’s phenol reagent (C) (p=0.3724), but these interactions 
are found to be insignificant as p>0.05. Volume of biuret reagent was 
found to affect the response more. An interaction plot is shown in Fig. 4.
Response surface and contour plots were also analyzed to visualize the 
effects of the parameters on the selected response R. Fig 4 shows the 
effects of volume of NaOH (A), volume of biuret reagent (B), and volume 
of Folin–Ciocalteau’s phenol reagent (C) on the selected response R.
It may be interpreted from the surface diagram that volume of biuret 
reagent (B) was in the range of 0.24-0.26 ml and that a volume of NaOH 
(A) in the range of 1.0–1.1 ml gives maximum absorbance (R) (Fig. 5a).
A volume of NaOH (A) was in the range of 1.0–1.1 ml and that a volume 
of Folin–Ciocalteu phenol reagent (C) in the range of 10–12 µL gives 
maximum absorbance (R) (Fig. 5b).
A volume of Folin–Ciocalteu phenol reagent (C) was in the range of 
10-12 µL and that a volume of biuret reagent (B) in the range of 0.25–
0.28 ml gives maximum absorbance (R) (Fig. 5c).
Model validation
The experimental results and the predicted values obtained using 
polynomial model show that the predicted values match the selected 
response R reasonably with an R2 of 96.65% and an R2 (adj) of 95.35%.
Fig. 6 shows the residual plots of the selected response R in 
model equation. The distribution of the residuals of the response 
approximately follows the fitted normal distribution, whereas the 
Fig. 2: First-order derivative spectra of standard serralysin 
in visible range after reaction with biuret reagent and Folin–
Ciocalteau’s reagent
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residuals of the response are randomly scattered in the residual 
plots.
Reaction mechanism
The proposed method involves copper chelation chemistry. The 
assay is performed in two distinct steps. In the first step, the protein 
reacts with Biuret reagent to form a tetradentate copper complex 
from four peptide bonds and one atom of copper. Second, a reaction 
with Folin–Ciocalteu’s phenol reagent in which a phosphomolybdic-
phosphotungstic acid solution is added. This compound (called Folin-
phenol reagent) becomes reduced and produces intense blue color. It 
is believed that the color enhancement occurs when the tetradentate 
copper complex transfers electrons to the phosphomolybdic-
phosphotungstic acid complex. Addition of NaOH makes the solution 
more alkaline and this is observed to enhance the color intensity and 
its stability.
Spectral characteristics
The scanning speed of 1000nm/min, data interval 0.5 nm, and UV 
response 0.96 seconds were selected as the instrumental parameters 
by OFAT method. The colored complex formed was observed to give 
a peak at 620 nm in the first-order derivative UV spectra when run 
against reagent blank prepared in similar manner except SER.
Choice of solvent for preparation of SER solution
Distilled water was selected as solvent for preparing SER solution 
considering solubility and stability.
Reagent solution
The Biuret reagent was used without dilution. The Folin–Ciocalteu’s 
reagent 2N was used in the assay.
Linearity study
A calibration graph of the SER concentration versus the absorbance 
was constructed for the method under optimized conditions. A linear 
relationship was observed in the concentration range of 0.1–4.0 mg/ml. 
The graph shows a good correlation coefficient (r2=0.9995) with the 
intercept (0.001) calculated using regression equation (Table 6)
Assay results of SER in pharmaceutical formulations
The results obtained from the analysis of marketed formulations are 
provided in Table 7. The percent purities of marketed formulations, 
namely, Bidanzen (5 mg) and Cipzen forte (10 mg) tablet were found to 
be 99.50±0.34 and 100.60±0.41, respectively.
Table 5: Estimated regression coefficient for selected response
Factor Coefficient estimate df SE 95% CI low 95% CI high
Intercept 1.002E-003 1 2.080E-005 9.525E-004 1.051E-003
A-volume of NaOH 4.023E-005 1 1.644E-005 1.344E-006 7.911E-005
B-volume of biuret reagent 1.251E-004 1 1.644E-005 8.622E-005 1.640E-004
C-volume of Folin–Ciocalteau’s phenol reagent 7.264E-005 1 1.644E-005 3.376E-005 1.115E-004
AB 2.407E-005 1 2.326E-005 −3.092E-005 7.906E-005
AC −5.996E-006 1 2.326E-005 −6.099E-005 4.899E-005
BC −2.216E-005 1 2.326E-005 −7.715E-005 3.283E-005
A2 −1.827E-004 1 2.267E-005 −2.363E-004 −1.292E-004
B2 −1.493E-004 1 2.267E-005 −2.029E-004 −9.569E-005
C2 −1.658E-005 1 2.267E-005 −7.017E-005 3.702E-005
SD=4.651E-005, Press=1.540E-007, R2=0.9665, adjusted R2=0.9535, predicted R2=0.6597. SD: Standard deviation, SE: Standard error, CI: Confidence interval
Fig. 5: Response surface plot of response R (a) A: Volume of NaOH 
versus B: Volume of Biuret reagent, (b) A: Volume of NaOH versus C: 
Volume of Folin–Ciocalteu’s phenol reagent, (c) B: Volume of biuret 
reagent versus C: Volume of Folin–Ciocalteu’s phenol reagent
a b
c
Table 4: Analysis of variance for selected response
Source Sum of squares df Mean square F p>F Inference
Model 4.372E-007 9 4.858E-008 22.46 0.0002 Significant
A-volume of NaOH 1.295E-008 1 1.295E-008 5.98 0.0443
B-volume of biuret reagent 1.252E-007 1 1.252E-007 57.88 0.0001
C-volume of Folin–Ciocalteau’s phenol reagent 4.221E-008 1 4.221E-008 19.51 0.0031
AB 2.317E-009 1 2.317E-009 1.07 0.3351
AC 1.438E-010 1 1.438E-010 0.066 0.8039
BC 1.964E-009 1 1.964E-009 0.91 0.3724
A2 1.406E-007 1 1.406E-007 65.00 < 0.0001
B2 9.384E-008 1 9.384E-008 43.38 0.0003
C2 1.157E-009 1 1.157E-009 0.53 0.4884
Residual 1.514E-008 7 2.163E-009
Lack of fit 9.025E-009 3 3.008E-009 1.97 0.2611 Not significant
Pure error 6.118E-009 4 1.529E-009
Total 4.524E-007 16
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Accuracy
The accuracy of the proposed method was determined through a 
recovery study. A known amount of pure SER was used to spike to pre-
analyzed tablet formulation. Analysis of SER was carried out at three 
concentration levels (80%, 100%, and 120%) within the specified 
linearity range. Determination of the SER content was carried out 
using the formula mentioned in the section titled “assay of SER in 
pharmaceutical formulations.” The percent recovery of the proposed 







where E = total amount of ser estimated (mg); T = amount of SER 
from pre-analysis of the tablet powder (mg); and P = amount of pure 
SER added (mg). The average percent recoveries for Bidanzen (5mg) 
and Cipzen forte (10 mg) tablet are found to be 101.02±0.64 and 
100.70±0.41, respectively (Table 8).
Precision
The interday precision and intraday precision of the method were 
determined. A repeatability study (intraday precision) was performed 
by analyzing a sample of SER repeatedly within a day. An interday 
precision study was performed by analyzing a sample of SER repeatedly 
at different days. The results of interday and intraday precision were 
expressed as %RSD and they were found to be 0.93 and 1.15, respectively. 
The %RSD value indicates that the method has good precision.
Limit of detection (LOD) and limit of quantitation (LOQ)
The LOD and LOQ of the analytical method developed for estimating the 
SER content were calculated using the following formulae.
LOD = (3.3×σ)⁄S
Fig. 6 Residual plots of response R
Table 6: Optical characteristics and statistical data of regression 
equations for the color reaction
Parameter SER color complex
pH Alkaline (~12.7)
Colour Intense blue
Derivative λmax 620 nm
Beer Lambert’s law limit (mg/ml) 0.1–4.0





Table 7: Determination of serralysin in pharmaceutical 
formulation








99.50±0.34 100.43±0.32 1.7548 0.7275
Cipzen forte 
(10 mg)
100.60±0.41 100.98±0.62 1.2811 0.7152
RSD: Ratio of the standard deviation
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LOQ = ((10×σ)⁄S
where σ = standard deviation of the response; and S = slope of 
calibration curve.
The LOD and limit of quantitation were found to be 1.2045 and 
4.2136 mg/mL, respectively.
Stability of solution
The solution used in the precision study was stored for 24 h at room 
temperature. During the storage period, the absorbance of the solution 
was measured after different time intervals (0, 15, 30 min, 1, 2, 3, 4, 5, 6, 
and 24 h), and it was found that the color intensity of the solution was 
stable up to 6 h.
Statistical analysis of data
The validity of the proposed method for determining the SER content 
in pharmaceutical formulations was tested by analyzing the SER using 
a previously developed HPLC method. The results of the statistical 
comparison are given in Table 7. At the 95% confidence level, the 
calculated t-value and F-value do not exceed the theoretical values 
for either Bidanzen (5 mg) or Cipzen forte (10 mg) tablet. Therefore, 
there is no significant difference between the proposed and reported 
methods, indicating that the proposed method is as accurate and 
precise as the reported method.
CONCLUSION
A two-level full factorial design was used to design an experimental 
program to extract data regarding influencing factors that had 
significant effects on the selected response (R). One-way ANOVA 
and Pareto ranking analyses showed that the volume of NaOH (A), 
volume of biuret reagent (B) and volume of Folin–Ciocalteu’s phenol 
reagent (C) were statistically significant factors (p<0.05) affecting the 
formation of the colored complex of SER and absorbance (R). A Box–
Behnken experimental design with RSM was then utilized to evaluate 
the main, interaction, and quadratic effects of these three factors on 
the selected response Y. With the help of a response surface plot and 
contour plot, the optimum values of the selected factors were identified. 
The predicted values of the response matched the experimental values 
reasonably well, with an R2 of 96.65% and an R2 (adj) of 95.35% for 
the selected response R. In order to gain a better understanding of 
the effects of the variables on the selected response R, the predicted 
model was presented in the form of a response surface and contour plot 
design. It was concluded that the experimental design concept could 
be effectively used to optimize a visible spectrophotometric method for 
estimating the SER content in bulk and pharmaceutical formulations 
with the least number of experimental runs possible.
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